IONS Chart
- 52-Week Range: $25.61 - $43.00
- Market Capitalization: $5.49B
- Short Percentage: 0%
- Target Price: $47.39
- Shares Outstanding: 141.80M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
IONS released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Ionis Pharmaceuticals, Inc. (IONS) CEO Brett Monia on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha | February 24th
- Ionis reports fourth quarter and full year 2021 financial results and recent business achievementsPRNewsWire | February 24th
- Ionis announces eplontersen receives orphan drug designation from U.S. FDAPRNewsWire | January 24th
- Moore Kuehn, PLLC Encourages Investors of Ionis Pharmaceuticals, Inc. to Contact Law FirmNewsfile Corp | January 20th
Company Info
Website: https://www.ionispharma.com
Address: 2855 Gazelle Court, Carlsbad, CA, United States, 92010
Sector: Healthcare
Industry: Biotechnology
Full time employees: 660
Address: 2855 Gazelle Court, Carlsbad, CA, United States, 92010
Sector: Healthcare
Industry: Biotechnology
Full time employees: 660
$IONS buy SHARES
$IONS buy bitches
$IONS just hold no panic
$IONS pre mkt is meaningless
$IONS strong move here
$IONS HOLDING STRONG FOR ALL OF YOU
$IONS we like the stock
$IONS down with Nasdaq. Let's go!